MedTrace Logo

Implementing Standards of Care for Heart Failure Patients in General Practice - A Regional Disease Management Program

NCT04334447 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2020-04-06

No results posted yet for this study

Summary

Heart failure (HF) is an important health problem. Most chronic HF management occurs in primary care. Although guidelines exist, there is an important implementation gap in current HF care in Belgium. We will conduct a non-randomized, non-controlled prospective observational trial to implement guideline-recommended best clinical practices in primary care in Leuven, a region of ± 100.000 inhabitants. These best clinical practices include education of general practitioners, access to natriuretic peptides and audits in the electronic health record (EHR), training and implementation of HF educators in primary care and a structured post-discharge transition process . The main objective is to implement best clinical practices in a dynamic way and study the implementation process. We will evaluate the implementation of several guideline-recommended best clinical practices to optimize the diagnosis and treatment of heart failure in a real-world primary care setting.

Conditions

Interventions

OTHER

Improved primary care HF diagnostics

Reimbursement of natriuretic peptide testing for participating general practitioners (GPs) Audit and feedback in GPs EHR

OTHER

Heart Failure education

Reimbursement of heart failure education for patients at risk. Web-based training for participating general practitioners

OTHER

Structured transitional protocol planning post-discharge care

Checklist-supported discharge protocol for HF patients including telephone contact with patients' general practitioners and a contact with the HF educator

Sponsors & Collaborators

  • KU Leuven

    lead OTHER

Principal Investigators

  • Bert Vaes · KU Leuven

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-04
Primary Completion
2021-12-31
Completion
2022-07-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04334447 on ClinicalTrials.gov